Abstract:
:Medically induced abortion using a new regimen of oral mifepristone 600 mg and vaginal misoprostol 800 micrograms (PGE1 analogue) was carried out in 100 women. Abortion occurred in all patients without resort to surgery. In 99 women, the abortion occurred within 4 hours of the administration of the prostaglandin. Sixty-seven patients did not request any form of analgesia. This regimen is highly effective, has a low incidence of side effects (mainly gastrointestinal) and appears to be highly acceptable to women. :Obstetrician-gynecologists recruited 100 women (mean age = 24.1 years and mean duration of amenorrhea = 51 days) attending the Aberdeen Royal Infirmary in Scotland to undergo elected abortion into an open study of the use of a new regimen of oral mifepristone (600 mg) and vaginally-administered misoprostol (800 mcg). This was the first pregnancy for 77 of the women. No surgical intervention was required in any of the cases. The conceptus was expelled and confirmed within 4 hours after administration of misoprostol in 99 women. The other woman aborted within 2 hours after an ultrasound scan. One women bled heavily and did not completely abort. She was readmitted to the hospital, where she received a blood transfusion. An oxytocic injection resulted in a complete abortion. One woman had a complete abortion with just mifepristone. Vomiting (17%) and diarrhea (12%) were the leading side effects. None of the women with these gastrointestinal effects needed any treatment. Most women (66%) did not ask for any analgesia. Bleeding after the abortion lasted on average 9.5 days. Before and after mean hemoglobin levels were similar (13.1 and 12.9, respectively). No one developed an infection. These findings support those of another study that misoprostol administered vaginally is much more effective at terminating pregnancy than when it is administered orally. They also show that women find vaginally administered misoprostol very acceptable.
journal_name
Contraceptionjournal_title
Contraceptionauthors
el-Refaey H,Templeton Adoi
10.1016/0010-7824(94)90085-xsubject
Has Abstractpub_date
1994-02-01 00:00:00pages
111-4issue
2eissn
0010-7824issn
1879-0518pii
0010-7824(94)90085-Xjournal_volume
49pub_type
杂志文章相关文献
CONTRACEPTION文献大全abstract::Emergency contraception promises to reduce Mexico's high unwanted pregnancy and unsafe abortion rates. Because oral contraceptives are sold over-the-counter, several emergency contraceptive regimens are already potentially available to those women who know about the method. Soon, specially packaged emergency contracep...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/s0010-7824(99)00088-8
更新日期:1999-10-01 00:00:00
abstract::With the objective of evaluating the ovulatory function among long-term Norplant implants users with regular menstrual cycles, we undertook this prospective study including 11 Norplant implants users and 11 control women who were not using hormonal methods of fertility control. Exposed and unexposed women had had at l...
journal_title:Contraception
pub_type: 临床试验,杂志文章
doi:10.1016/s0010-7824(96)00179-5
更新日期:1996-11-01 00:00:00
abstract:OBJECTIVE:To assess patterns of contraceptive use at last intercourse among women with physical or cognitive disabilities compared to women without disabilities. STUDY DESIGN:We analyzed responses to 12 reproductive health questions added by seven states to their 2013 Behavioral Risk Factor Surveillance System questio...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2017.12.008
更新日期:2018-06-01 00:00:00
abstract::STS 557 (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4.9(10)-diene-3-one) is a potent progestin. This compound was 10 times as potent as the standard levonorgestrel as judged by the classic Clauberg-McPhail Assay. The antiprogestational response is significant when STS 557 treatment starts 2 days before progesterone ad...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(80)90140-7
更新日期:1980-01-01 00:00:00
abstract::Plasma concentrations of levonorgestrel, progesterone, estradiol, FSH and LH were measured in seven volunteers who had a levonorgestrel-releasing IUD inserted postmenstrually. Blood samples were collected twice weekly during a mean of 93 days immediately postmenstrually and during a mean of 41 days over the twelfth to...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(80)90003-7
更新日期:1980-03-01 00:00:00
abstract:OBJECTIVE:We sought to qualitatively understand patients' experiences with digoxin as a step before dilation and evacuation (D&E). STUDY DESIGN:We recruited English-speaking women from one abortion health center where digoxin is routinely used before D&E. We interviewed participants one to three weeks after the D&E ab...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2018.02.004
更新日期:2018-06-01 00:00:00
abstract::The present study was designed to evaluate the effectiveness of a once-weekly regimen of GnRH antagonist followed by a progestin as a potential new contraceptive method. On menstrual cycle days 2, 9, 16, and 23 (onset of menses = Day 1) monkeys were divided into two groups: 1) those injected sc with 0.1 mg/kg Nal-Glu ...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/s0010-7824(09)91007-1
更新日期:1990-06-01 00:00:00
abstract::Data from published studies of the quantity of medroxyprogesterone acetate and/or its metabolites in the milk of lactating women receiving Depo-Provera for contraception is extrapolated into the amount of drug ingested daily by a theoretically average infant. Comparisons are made with the results of similar studies in...
journal_title:Contraception
pub_type: 杂志文章,评审
doi:10.1016/0010-7824(81)90027-5
更新日期:1981-04-01 00:00:00
abstract::The metabolic effects of a new oral contraceptive Femodene (SHD 356C) containing 75 micrograms gestodene (delta-15-levonorgestrel) and 30 micrograms ethinyloestradiol were studied in two groups of women. Group 1 consisted of women not currently using oral contraceptives; Group 2 consisted of women switching to Femoden...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(87)90069-2
更新日期:1987-04-01 00:00:00
abstract::Differential precipitation of plasma proteins after equilibration of the plasma with tracer amounts of testosterone (T) was used to measure free and not-T-estradiol binding globulin (TeBG)-bound T in 20 women and 10 men. Tritiated T was the tracer used. Comparison of this method with the equilibration dialysis metho...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(74)90099-7
更新日期:1974-12-01 00:00:00
abstract::The study was conducted to profile women seeking abortions at the National University Hospital, with particular interest in the trend of teenage pregnancies with the aim of identifying risk factors for late presentation for abortions. All patients who underwent an abortion at our center from January 1, 1996 to Decembe...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/s0010-7824(02)00317-7
更新日期:2002-07-01 00:00:00
abstract::A 10% sample of the data from East China from the two-per-thousand fertility and contraception survey of the Chinese State Family Planning Committee was analysed to study determinants of contraceptive choice in three situations: after first surviving delivery; before first abortion after first surviving delivery; and ...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(93)90022-y
更新日期:1993-06-01 00:00:00
abstract::To study the effect of Stryphnodendron polliphyllum M. upon implantation, the seeds and empty pods of this plant were given to pregnant rats, on the 5th and 6th days of gestation. The animals were sacrificed on the 14th day of pregnancy and implantation and resorption indices were studied. The results show definite em...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/s0010-7824(79)80045-1
更新日期:1979-10-01 00:00:00
abstract:BACKGROUND:The adverse effects of copper intrauterine devices (IUDs) such as abnormal bleeding, pain and cramps may be due in part to the burst release of copper ions during the first few months of usage. This study focuses on controlling the initial burst release of copper ions. STUDY DESIGN:This study evaluated in v...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2015.08.014
更新日期:2015-12-01 00:00:00
abstract:PURPOSE:This prospective study aimed to assess the possible effects of the levonorgestrel-releasing intrauterine system (LNG-IUS) on serum lipids and fasting blood glucose levels over a period of 1 year. METHODS:Forty-eight premenopausal women, attending our gynecology clinic with the complaint of menorrhagia, were en...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2005.12.005
更新日期:2006-05-01 00:00:00
abstract::The aim of this study was to compare contraceptive reliability, cycle control, and tolerance of an oral contraceptive containing 20 micrograms ethinylestradiol (EE2) and 75 micrograms gestodene (GSD), with a reference preparation containing a similar dose of gestodene but in combination with 30 micrograms ethinylestra...
journal_title:Contraception
pub_type: 临床试验,杂志文章,多中心研究,随机对照试验
doi:10.1016/s0010-7824(97)00025-5
更新日期:1997-03-01 00:00:00
abstract:BACKGROUND:Weight gain is commonly reported as a side effect of hormonal contraception and can lead to method discontinuation or reluctance to initiate the method. The purpose of this study was to investigate weight change in adolescent (aged 15-19 years) users of depot-medroxyprogesterone acetate (DMPA), norethisteron...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2009.07.007
更新日期:2010-01-01 00:00:00
abstract:OBJECTIVES:As obesity may affect the efficacy of some contraceptives, we examined weight, body mass index (BMI) and prevalence of obesity among female contraceptive clients at 231 U.S. health centers. A secondary aim was to analyze differences in contraceptive method use by obesity status. STUDY DESIGN:Cross-sectional...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2015.02.006
更新日期:2015-06-01 00:00:00
abstract:BACKGROUND:Questions remain regarding whether oral contraceptive (OC) use among women with a family history of breast cancer increases disease risk. STUDY DESIGN:We conducted a systematic review by searching MEDLINE and CENTRAL databases for evidence (in all languages) published in peer-reviewed journals from 1966 to ...
journal_title:Contraception
pub_type: 杂志文章,评审
doi:10.1016/j.contraception.2009.04.010
更新日期:2009-10-01 00:00:00
abstract:BACKGROUND:Potential barriers to intrauterine device (IUD) use include provider concern about difficult insertion, particularly for nulliparous women. OBJECTIVE:This study aims to evaluate the evidence on the effectiveness of medications to ease IUD insertion on provider outcomes (i.e., ease of insertion, need for adj...
journal_title:Contraception
pub_type: 杂志文章,评审
doi:10.1016/j.contraception.2016.06.014
更新日期:2016-12-01 00:00:00
abstract::First year results of a randomized study of 1509 users of the Copper T380Ag with a silver core or of an IUD releasing 20 mcg day of levonorgestrel are reported. The cumulative gross pregnancy rate for each device was 0.3 per 100 at one year, with more than 490 women having one year of use with each device. The levonor...
journal_title:Contraception
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1016/0010-7824(84)90036-2
更新日期:1984-11-01 00:00:00
abstract:BACKGROUND:New strategies are needed for preventing HIV infection in women. One potential approach is female-initiated use of an effective topical microbicidal gel in combination with a cervical barrier such as the diaphragm. STUDY DESIGN:Randomized, placebo-controlled safety and feasibility trial of diaphragm with va...
journal_title:Contraception
pub_type: 杂志文章,随机对照试验
doi:10.1016/j.contraception.2009.10.011
更新日期:2010-03-01 00:00:00
abstract:PURPOSE:This prospective observational study evaluated the bleeding patterns of adolescents receiving a monthly injectable contraceptive containing norethisterone enanthate 50 mg plus estradiol valerate 5 mg. MATERIALS AND METHODS:The study enrolled 73 volunteers aged between 14 and 19 years; of these patients, 38 (52...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2006.01.009
更新日期:2006-06-01 00:00:00
abstract::The temporal effects of oral administration of cyproterone acetate (CPA), a progestational androgen receptor blocker, were studied on the fertility of adult male rat sires, at a dose of 20 mg kg-1 day-1 after 15 days of gavage. The treatment reduced the fertility and weights of accessory sex glands, without altering t...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2004.11.003
更新日期:2005-05-01 00:00:00
abstract::Levels of immunoreactive follitropin (FSH), lutropin (LH), estradiol, progesterone, 17-hydroxyprogesterone and 20 alpha-dihydroprogesterone were analyzed in peripheral plasma samples collected daily from 21 normally menstruating women during a pretreatment (control) cycle and during months 2 and 6 of administration of...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(81)90049-4
更新日期:1981-03-01 00:00:00
abstract:PURPOSE:The purpose of this study was to explore the relationship between oral contraceptive pill (OCP) use and the experience of depressive symptoms among a representative sample of young Australian women. METHODS:The study sample comes from the Australian Longitudinal Study on Women's Health. Analysis was confined t...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2006.08.002
更新日期:2007-01-01 00:00:00
abstract:OBJECTIVES:The Natural Cycles application is a fertility awareness-based contraceptive method that uses dates of menstruation and basal body temperature to inform couples whether protected intercourse is needed to prevent pregnancies. Our purpose with this study is to investigate the contraceptive efficacy of the mobil...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2017.08.014
更新日期:2017-12-01 00:00:00
abstract::With an ever-increasing number of reproductive-aged women undergoing solid organ transplant and fertility improving after transplant, knowledge of the safety and efficacy of various contraceptive methods is essential to guide patient selection. We present the case of a 22-year-old patient desiring an intrauterine devi...
journal_title:Contraception
pub_type: 杂志文章,评审
doi:10.1016/j.contraception.2019.05.012
更新日期:2019-09-01 00:00:00
abstract:BACKGROUND:The FDA approval of mifepristone in 2000 broadened the available options for abortion. The aim of this study was to evaluate whether physicians in New Mexico have integrated the use of mifepristone into their practice. STUDY DESIGN:We performed a mail-out survey of New Mexico Obstetrician Gynecologists (Ob-...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2010.11.021
更新日期:2011-08-01 00:00:00
abstract::In order to determine whether inhibition of the endometrial estradiol-17 beta-dehydrogenase activity by Cu++ could be one of the factors accounting for the enhanced contraceptive efficacy of copper intrauterine devices (Cu-IUD), the activity of the enzyme was measured in endometrial biopsies from women wearing this de...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(79)90019-2
更新日期:1979-03-01 00:00:00